Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

NASDAQ Biotechnology (NBI)

NASDAQ
Currency in USD
4,606.2
-111.4(-2.36%)
Closed

NASDAQ Biotechnology Discussions

big opportunity on the euronex with abionyx pharma...they will produce very good résults they had on the septcis in the next weeks...their product cer001 is the only one at this stage that will save the life of more than 35million People in the world...it has also very good results in other rare deseases
Worst sector ever 😂
think it's about time to start loading up
Pfizer and biontech are fraudulent companies.
The news about the biontech vaccine is said to be false.
The news about the biontech vaccine turned out to be false.
Sundial growers next week 1,5 $
NBI -- TF = Daily -- DOUBLE TOP -- BREAKDOWN -- NASDAQ BIOTECHNOLOGY SECTOR IN BIG TROUBLE -- STRONG SELL --  https://invst.ly/pp2vy
4 hour chart - buy !. . . https://invst.ly/pfvhr
CUP WITH HANDLE .. Seems to continue and strengthen. .. https://invst.ly/pfv7k. . . Want a strong growth company ?. . . Look at chemm.co , Denmark. Now rising after a period of consolidation. see you up there !
CUP WITH HANDLE READY !!!. . . https://invst.ly/ot6z-. . . Bought a lot of Genmab = gen.co
Trump says "Favored Nation" drug plan would lower U.S. prices - Bloomberg _00:45_July 9_3365.3 (-70.2)
good performance
https://pharmaphorum.com/news/gilead-make-move-galapagos-within-weeks
Biotech stocks are still relatively undervalued after the 2015-21016 meltdown of 30% stock value , which devalued good as well as poor companies as fear motivated decision making.  2017 has already seen over 20 new drugs approved by the FDA so far this year, with more to come in the second half of the year.  Many small and medium companies are doing well with new drugs brought to market, so a period of steady growth in revenue is predicted for 2017-2018.  Regards,  Dr. John Whitehead (26 years in R&D in pharmaceuticals)
eu atak !!!
Nasdaq Biotech back again, thanks Clinton hope you never back again
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.